Figure S8 from A Randomized Phase II Study: CRS207/GVAX plus Anti–PD‐1 and Anti-CTLA4 Recruits Mesothelin- and mKRAS-Specific T Cells into PDAC
Abstract
Expression profiles of immune cell clusters using a myeloid-focused panel of antibodies
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Pancreatic and Hepatic Oncology Research
Immunotherapy and Immune Responses
Publication details
- Publication date
- 4 March 2026
- Language
- EN